BCM
KRRO icon

Bridgeway Capital Management’s Korro Bio KRRO Stock Holding History

Bridgeway Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,014
Closed -$25.5K – 1421
2023
Q1 		$25.5K Sell
1,014
-760
-43% -$86.6K ﹤0.01% 1349
2022
Q4 		$341K Hold
1,774
– – 0.01% 963
2022
Q3 		$159K Hold
1,774
– – ﹤0.01% 1179
2022
Q2 		$133K Hold
1,774
– – ﹤0.01% 1174
2022
Q1 		$188K Hold
1,774
– – ﹤0.01% 1181
2021
Q4 		$455K Buy
+1,774
New +$539K 0.01% 1006

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.56B AUM 17.72% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return

Bridgeway Capital Management's KRRO Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Korro Bio (KRRO) in Q2 2023, closing a stake of 1,014 shares — an estimated $25.5K sold.

Bridgeway Capital Management first reported a position in KRRO in Q4 2021 and held it in 6 quarters. The position peaked at $455K in Q4 2021. 41 funds tracked by Wall St. Rank hold KRRO as of Q2 2023.

  • Bridgeway Capital Management reported no remaining Korro Bio position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 1,014 Korro Bio shares in Q2 2023, an estimated $25.5K.
  • Bridgeway Capital Management first reported a position in Korro Bio in Q4 2021 and held it in 6 quarters.
  • Bridgeway Capital Management's Korro Bio position peaked at $455K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Korro Bio as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.